OncoMed Pharmaceuticals Inc Diluted Shares Outstanding (Weighted Average)
OncoMed Pharmaceuticals Inc reported Diluted Shares Outstanding (Weighted Average) of 38.51 million shares for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2018-11-01
- OncoMed Pharmaceuticals Inc weighted average number of shares outstanding, diluted for the quarter ending 2018-09-30 was 38.51M shares, a 2.26% increase year-over-year.
- OncoMed Pharmaceuticals Inc weighted average number of shares outstanding, diluted for the quarter ending 2017-09-30 was 37.66M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 9 month |
|---|---|---|
| 2018-09-30 | 38.51M shares 10-Q · filed 2018-11-01 | 38.38M shares 10-Q · filed 2018-11-01 |
| 2017-09-30 | 37.66M shares 10-Q · filed 2018-11-01 | 37.52M shares 10-Q · filed 2018-11-01 |